ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,798,000 | +10.9% | 1,658,188 | -3.4% | 0.00% | 0.0% |
| Q4 2021 | $6,128,000 | -3.1% | 1,716,433 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $6,326,000 | -17.5% | 1,737,750 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $7,668,000 | +5.5% | 1,758,725 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $7,265,000 | -3.3% | 1,767,291 | -6.1% | 0.00% | 0.0% |
| Q4 2020 | $7,511,000 | +44.2% | 1,882,201 | -2.4% | 0.00% | 0.0% |
| Q3 2020 | $5,207,000 | -7.3% | 1,928,417 | -5.6% | 0.00% | 0.0% |
| Q2 2020 | $5,615,000 | +22.6% | 2,041,783 | +5.2% | 0.00% | 0.0% |
| Q1 2020 | $4,581,000 | -49.9% | 1,941,520 | -0.2% | 0.00% | -50.0% |
| Q4 2019 | $9,144,000 | +22.4% | 1,945,617 | -12.9% | 0.00% | 0.0% |
| Q3 2019 | $7,473,000 | +26.3% | 2,233,959 | +24.2% | 0.00% | +100.0% |
| Q2 2019 | $5,918,000 | +10.4% | 1,799,058 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $5,361,000 | +13.1% | 1,769,480 | +1.6% | 0.00% | 0.0% |
| Q4 2018 | $4,738,000 | -18.7% | 1,741,602 | +0.4% | 0.00% | 0.0% |
| Q3 2018 | $5,828,000 | +31.5% | 1,734,734 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $4,433,000 | +26.0% | 1,718,251 | +7.4% | 0.00% | 0.0% |
| Q1 2018 | $3,518,000 | +9.4% | 1,599,160 | -1.0% | 0.00% | 0.0% |
| Q4 2017 | $3,216,000 | -39.0% | 1,616,011 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $5,276,000 | -1.0% | 1,628,295 | -1.6% | 0.00% | 0.0% |
| Q2 2017 | $5,327,000 | +555.2% | 1,654,266 | +478.1% | 0.00% | – |
| Q1 2017 | $813,000 | +31.8% | 286,135 | +8.0% | 0.00% | – |
| Q4 2016 | $617,000 | +32.1% | 264,972 | -4.8% | 0.00% | – |
| Q3 2016 | $467,000 | +76.2% | 278,214 | +10.3% | 0.00% | – |
| Q2 2016 | $265,000 | -81.5% | 252,188 | -84.7% | 0.00% | – |
| Q1 2016 | $1,435,000 | -27.9% | 1,649,331 | +0.3% | 0.00% | -100.0% |
| Q4 2015 | $1,989,000 | -28.0% | 1,643,824 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $2,761,000 | -9.8% | 1,624,151 | +10.4% | 0.00% | 0.0% |
| Q2 2015 | $3,060,000 | -11.1% | 1,471,686 | +15.9% | 0.00% | 0.0% |
| Q1 2015 | $3,442,000 | +5.6% | 1,270,136 | +0.1% | 0.00% | 0.0% |
| Q4 2014 | $3,260,000 | +34.7% | 1,268,650 | -4.1% | 0.00% | 0.0% |
| Q3 2014 | $2,420,000 | -31.0% | 1,322,272 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $3,507,000 | -31.7% | 1,313,397 | -10.5% | 0.00% | -50.0% |
| Q1 2014 | $5,137,000 | -28.3% | 1,468,000 | -8.3% | 0.00% | 0.0% |
| Q4 2013 | $7,160,000 | +11.8% | 1,601,589 | +1.5% | 0.00% | 0.0% |
| Q3 2013 | $6,407,000 | +1.6% | 1,578,165 | +4.2% | 0.00% | 0.0% |
| Q2 2013 | $6,304,000 | – | 1,515,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |